Overview


According to FutureWise analysis, the market for Aerosol Delivery Devices is expected to reach US$ 57.02 billion by 2031 at a CAGR of 5.12% over the forecast period of 2023-2031.

The delivery of aerosol medication directly to the airways is a mainstay in emergency treatment and long-term management of COPD, asthma, and other chronic lung diseases in adult and pediatric populations. Aerosol delivery devices have been evolved over more than sixty years from the basic pressurized metered-dose inhaler and nebulizer to various types of inhalers and devices, including dry powder inhalers, soft mist inhalers, valved holder chambers, as well as smart inhalers and nebulizers. Although these devices improved patients' ability to self-administer medication, many problems with optimal delivery still need to be solved. Appropriate selection and repeated patient education can lessen the issues with these devices. Understanding the clinical application and science of aerosol drug delivery devices can substantially help clinicians optimize these therapies for their patients. Currently, ultrasonic nebulizers and jets are most widely used to administer mainly antimicrobial drugs against various lung infections, chemotherapeutics for lung cancer treatment, and provocative agents in bronchial challenge tests.

Nebulizers convert solutions or suspensions into aerosols, producing particles of a size suitable for inhalation into the lower respiratory tract. There are ultrasonic nebulizers, pneumatic jet nebulizers, and mesh nebulizers. The latest nebulizer designs are breath-enhanced, breath-actuated, or have aerosol storage bags to minimize aerosol loss during exhalation. Nebulizers can be used with a helium-oxygen mixture and for continuous aerosol delivery. Recently, a growing focus has been on concerns associated with using a facemask alongside a nebulizer. The pressurized metered-dose inhaler (pMDI) is a widely used aerosol delivery device in press-and-breathe and breath-actuated designs. Issues related to pMDIs that include increasing attention are the conversion to hydrofluoroalkane fuel and dose counters. Many patients need better pMDI techniques.

FutureWise Market Research has published a report that provides an insightful analysis aerosol delivery devices market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, aerosol delivery devices market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  •  3M Company
  •  Aerogen
  •  GlaxoSmithKline plc.
  •  Johnson and Johnson
  •  Koninklijke Philips N.V.
  •  MerckCo. Inc.
  •  Metall Zug AG
  •  Recipharm AB (publ)
  •  Teva Pharmaceutical Industries Ltd.
  •  Vectura Group plc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Adult Medical Imaging Market:

  • In July 2022- Transpire Bio partnered with Recipharm to develop an inhalation medication.

An increase in the prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis is expected to dominate the growth of the aerosol delivery devices market during the forecast period. The aging global population contributes to a higher incidence of respiratory disorders, leading to a greater demand for effective inhalation therapies. These respiratory conditions have risen globally, increasing the need for efficient and targeted drug delivery methods. Aerosol delivery devices offer advantages such as ease of use, precise drug administration, and rapid relief of symptoms, making them essential to respiratory disease management. Additionally, advancements in medical technology, the introduction of smart inhalers, and the development of novel drugs tailored for inhalation therapy are fueling the adoption of aerosol delivery devices in treating and managing respiratory disorders. For instance, asthma is a major chronic respiratory disease affecting both adults and children. According to the data released by the WHO in 2021, approximately 262 million individuals worldwide were affected by asthma in 2019. The report also stated that most of the asthma-related cases occurred in low- and lower-middle-income countries. Furthermore, the high cost of advanced devices may be a significant barrier to widespread adoption in the aerosol delivery devices market. For patients, the affordability of these devices may be a concern, leading to limited access to cutting-edge treatment options. Healthcare providers may face challenges justifying the high costs, affecting their willingness to prescribe or recommend these devices. Additionally, research organizations and healthcare providers might be reluctant to allocate resources for expensive aerosol delivery devices, further impeding market growth.

By Product

  •  Dry Powder Inhalers
    •  Single Dose Inhalers
    •  Multi Dose Inhalers
  •  Metered Dose Inhalers
    •  Conventional Pressurized Inhalers
    •  Soft Mist Inhalers
  •  Nebulizers
    •  Jet Nebulizers
    •  Ultrasonic Wave Nebulizers
    •  Vibrating Mesh Nebulizer

By Application

  •  Asthma
  •  Chronic Obstructive Pulmonary Disease (COPD)
  •  Cystic Fibrosis
  •  Non-Respiratory Diseases
    •  Diabetes
    •  Analgesia
    •  Parkinson’s Disease

By Distribution Channel

  •  Retail Pharmacies
  •  Hospital Pharmacies
  •  Online Stores

By Region

  •  North America
  •  Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Owing to the rising prevalence of COPD in the region. Additionally, there is an increase in the adoption of technologically advanced Aerosol Delivery Devices, growing product launches associated with inhalers in the region, well-established healthcare facilities, and rising government programs to raise awareness regarding respiratory disorders and their proper management in the region, among others. Moreover, more research and development are being done; products in various stages of growth for the pipeline, such as VR647, LIQ861, and APC-4000, and cutting-edge tools are readily available. The factors mentioned above are further expected to drive the target market.

  •  Tier 1 players- established companies in the market with a major market share
  •  Tier 2 players
  •  Emerging players which are growing rapidly
  •  New Entrants

  •  Growth prospects
  •  SWOT analysis
  •  Key trends
  •  Key data-points affecting market growth

  • To provide with an exhaustive analysis on the aerosol delivery devices market By Product, By Application, By Distribution Channel and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  •  The customization Mobility Care offered are free of charge with purchase of any license of the report
  •  You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Aerosol Delivery Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Aerosol Delivery Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Aerosol Delivery Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Aerosol Delivery Devices Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Dry Powder Inhalers
         1.1. Single Dose Inhalers
         1.2. Multi Dose Inhalers
        2. Metered Dose Inhalers
         2.1. Conventional Pressurized Inhalers
         2.2. Soft Mist Inhalers
        3. Nebulizers
         3.1. Jet Nebulizers
         3.2. Ultrasonic Wave Nebulizers
         3.3. Vibrating Mesh Nebulizers

  • 8.   Aerosol Delivery Devices Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Asthma
        2. Chronic Obstructive Pulmonary Disease (COPD)
        3. Cystic Fibrosis
        4. Non-Respiratory Diseases
         4.1. Diabetes
         4.2. Analgesia
         4.3. Parkinson’s Disease

  • 9.   Aerosol Delivery Devices Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Online Stores

  • 10.   North America Aerosol Delivery Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Aerosol Delivery Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Aerosol Delivery Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Aerosol Delivery Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. 3M Company
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Aerogen
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. GlaxoSmithKline plc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Johnson & Johnson
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Koninklijke Philips N.V.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. MerckCo. Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Metall Zug AG
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Recipharm AB (publ)
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Teva Pharmaceutical Industries Ltd.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
         10. Vectura Group plc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients